208 related articles for article (PubMed ID: 27338036)
1. Clinical Practice Patterns of Radiotherapy in Patients with Hepatocellular Carcinoma: A Korean Radiation Oncology Group Study (KROG 14-07).
Cha H; Park HC; Yu JI; Kim TH; Nam TK; Yoon SM; Yoon WS; Kim JW; Kim MS; Jang HS; Choi Y; Kim JH; Kay CS; Jung I; Seong J
Cancer Res Treat; 2017 Jan; 49(1):61-69. PubMed ID: 27338036
[TBL] [Abstract][Full Text] [Related]
2. Treatment Outcome after Fractionated Conformal Radiotherapy for Hepatocellular Carcinoma in Patients with Child-Pugh Classification B in Korea (KROG 16-05).
Bae SH; Park HC; Yoon WS; Yoon SM; Jung IH; Lee IJ; Kim JW; Seong J; Kim TH; Nam TK; Choi Y; Lee SY; Jang HS; Lee DS; Kim JH
Cancer Res Treat; 2019 Oct; 51(4):1589-1599. PubMed ID: 30971065
[TBL] [Abstract][Full Text] [Related]
3. Practical patterns for stereotactic body radiotherapy to hepatocellular carcinoma in Korea: a survey of the Korean Stereotactic Radiosurgery Group.
Bae SH; Kim MS; Jang WI; Kay CS; Kim W; Kim ES; Kim JH; Kim JH; Yang KM; Lee KC; Chang AR; Jo S
Jpn J Clin Oncol; 2016 Apr; 46(4):363-9. PubMed ID: 26826720
[TBL] [Abstract][Full Text] [Related]
4. Epidemiology, clinical-treatment patterns and outcome in 256 hepatocellular carcinoma cases.
Fenoglio L; Serraino C; Castagna E; Cardellicchio A; Pomero F; Grosso M; Senore C
World J Gastroenterol; 2013 Jun; 19(21):3207-16. PubMed ID: 23745022
[TBL] [Abstract][Full Text] [Related]
5. Three-dimensional conformal radiotherapy for portal vein thrombosis of hepatocellular carcinoma.
Kim DY; Park W; Lim DH; Lee JH; Yoo BC; Paik SW; Kho KC; Kim TH; Ahn YC; Huh SJ
Cancer; 2005 Jun; 103(11):2419-26. PubMed ID: 15822130
[TBL] [Abstract][Full Text] [Related]
6. Prognostic indicators for radiotherapy of abdominal lymph node metastases from hepatocellular carcinoma.
Lee DY; Park JW; Kim TH; Lee JH; Kim BH; Woo SM; Kim SS; Lee WJ; Kim DY; Kim CM
Strahlenther Onkol; 2015 Nov; 191(11):835-44. PubMed ID: 26174506
[TBL] [Abstract][Full Text] [Related]
7. A multicenter retrospective cohort study of practice patterns and clinical outcome on radiotherapy for hepatocellular carcinoma in Korea.
Seong J; Lee IJ; Shim SJ; Lim DH; Kim TH; Kim JH; Jang HS; Kim MS; Chie EK; Kim JH; Nam TK; Lee HS; Han CJ
Liver Int; 2009 Feb; 29(2):147-52. PubMed ID: 18795897
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of tumor volume and radiation dose in moderate-sized hepatocellular carcinoma: A multicenter analysis in Korea (KROG 14-17).
Kim M; Kay CS; Jang WI; Kim MS; Lee DS; Jang HS
Medicine (Baltimore); 2017 Jun; 96(24):e7202. PubMed ID: 28614265
[TBL] [Abstract][Full Text] [Related]
9. Noninvasive Diagnosis of Hepatocellular Carcinoma: Elaboration on Korean Liver Cancer Study Group-National Cancer Center Korea Practice Guidelines Compared with Other Guidelines and Remaining Issues.
Yoon JH; Park JW; Lee JM
Korean J Radiol; 2016; 17(1):7-24. PubMed ID: 26798212
[TBL] [Abstract][Full Text] [Related]
10. Variation in Practice Patterns of Korean Radiation Oncologists for Spine Metastasis between 2009 and 2014.
Yu JI; Park HC; Ahn YC; Chung Y; Koom WS; Song SY
Cancer Res Treat; 2016 Jul; 48(3):1102-9. PubMed ID: 26639199
[TBL] [Abstract][Full Text] [Related]
11. 2014 KLCSG-NCC Korea Practice Guidelines for the management of hepatocellular carcinoma: HCC diagnostic algorithm.
Lee JM; Park JW; Choi BI
Dig Dis; 2014; 32(6):764-77. PubMed ID: 25376295
[TBL] [Abstract][Full Text] [Related]
12. Radiotherapy for Hepatocellular Carcinoma in Russia: a Survey-Based Analysis of Current Practice and the Impact of an Educational Workshop on Clinical Expertise.
Mitin T; Degnin C; Chen Y; Shirvani S; Gillespie E; Hoffe S; Latifi K; Nabavizadeh N; Dengina N; Chernich M; Usychkin S; Kharitonova E; Egorova Y; Pankratov A; Tsimafeyeu I; Thomas CR; Tjulandin S; Likhacheva A
J Cancer Educ; 2020 Feb; 35(1):105-111. PubMed ID: 30467774
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of stereotactic body radiotherapy for hepatocellular carcinoma with portal vein tumor thrombosis/inferior vena cava tumor thrombosis: evaluation by comparison with conventional three-dimensional conformal radiotherapy.
Matsuo Y; Yoshida K; Nishimura H; Ejima Y; Miyawaki D; Uezono H; Ishihara T; Mayahara H; Fukumoto T; Ku Y; Yamaguchi M; Sugimoto K; Sasaki R
J Radiat Res; 2016 Sep; 57(5):512-523. PubMed ID: 27053259
[TBL] [Abstract][Full Text] [Related]
14. Stereotactic body radiation therapy for hepatocellular carcinoma: Practice patterns, dose selection and factors impacting survival.
Robbins JR; Schmid RK; Hammad AY; Gamblin TC; Erickson BA
Cancer Med; 2019 Mar; 8(3):928-938. PubMed ID: 30701703
[TBL] [Abstract][Full Text] [Related]
15. The efficacy of high-dose 3-dimensional conformal radiation therapy in patients with small hepatocellular carcinoma not eligible for other local modalities.
Lim DH; Lee H; Park HC; Lee JA; Kim SW; Yoo BC; Koh KC; Lee JH; Choi MS; Gwak GY; Paik SW
Am J Clin Oncol; 2013 Apr; 36(2):162-6. PubMed ID: 22391433
[TBL] [Abstract][Full Text] [Related]
16. The HepCar registry: report on a one-year registration program of hepatocellular carcinoma (HCC) in Belgium. What is daily practice in HCC?
Van Vlierberghe H; Colle I; Henrion J; Michielsen P; Delwaide J; Reynaert H; Borbath I; Martinet JP; Sprengers D; Brenard R;
Acta Gastroenterol Belg; 2005; 68(4):403-11. PubMed ID: 16432990
[TBL] [Abstract][Full Text] [Related]
17. Study of local three-dimensional conformal radiotherapy combined with transcatheter arterial chemoembolization for patients with stage III hepatocellular carcinoma.
Li B; Yu J; Wang L; Li C; Zhou T; Zhai L; Xing L
Am J Clin Oncol; 2003 Aug; 26(4):e92-9. PubMed ID: 12902905
[TBL] [Abstract][Full Text] [Related]
18. A prospective phase 2 multicenter study for the efficacy of radiation therapy following incomplete transarterial chemoembolization in unresectable hepatocellular carcinoma.
Choi C; Koom WS; Kim TH; Yoon SM; Kim JH; Lee HS; Nam TK; Seong J
Int J Radiat Oncol Biol Phys; 2014 Dec; 90(5):1051-60. PubMed ID: 25303890
[TBL] [Abstract][Full Text] [Related]
19. Long-term outcomes of the 2-week schedule of hypofractionated radiotherapy for recurrent hepatocellular carcinoma.
Park J; Jung J; Kim D; Jung IH; Park JH; Kim JH; Lee SW; Yoon SM
BMC Cancer; 2018 Oct; 18(1):1040. PubMed ID: 30367606
[TBL] [Abstract][Full Text] [Related]
20. The feasibility of combined transcatheter arterial chemoembolization and radiotherapy for advanced hepatocellular carcinoma.
Cho JY; Paik YH; Park HC; Yu JI; Sohn W; Gwak GY; Choi MS; Lee JH; Koh KC; Paik SW; Yoo BC
Liver Int; 2014 May; 34(5):795-801. PubMed ID: 24350564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
